NVCR logo

NovoCure Limited (NVCR)

Profile

Full Name

NovoCure Limited

Ticker Symbol

NVCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

Switzerland

IPO

October 1, 2015

Indexes

Not included

Website

http://www.novocure.com

Employees

1488

Key Details

Price

$15.58(-1.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$605.22M(+18.82% YoY)

Annual EPS

-$1.56(+20.00% YoY)

PE ratio

-

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$15.58
NVCR price is $15.58

30-Day Relative Volume

0.86
NVCR 30-day relative volume is 0.86

Price Performance

Price Most recent change

-1.58%
NVCR price was down -1.58% on Apr 17, 2025

Price YTD change

-47.72%
NVCR price is down -47.72% since January 1st

Price 1-year change

+29.29%
NVCR price is up +29.29% year-on-year

Price 3-year change

-81.51%
NVCR price is down -81.51% over the past 3 years

Price Range

Price All-time high

$232.76
NVCR price is currently -93.31% below its historical high of $232.76

Price 3-year low

$10.87
NVCR price is currently +43.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.71B
NVCR market capitalization is $1.71 billion

Market cap 3-year change

-80.56%
NVCR market capitalization is down -80.56% over the past 3 years

Market cap All-time high

$23.33B
NVCR market capitalization is currently -92.66% below its historical high of $23.33 billion

Market cap sector rank

81.83%
NVCR market capitalization is higher than 81.83% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.15%
NVCR shares outstanding is up +2.15% year-on-year

Shares Outstanding 3-Year Change

+5.11%
NVCR shares outstanding is up +5.11% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.15
NVCR beta is 1.15

200-day SMA

$20.38
NVCR price is currently -23.54% below its 200-day simple moving average

50-day SMA

$19.30
NVCR price is currently -19.27% below its 50-day simple moving average

RSI

34.25
NVCR 14-day relative strength index is 34.25

Volume

0.86
NVCR 30-day relative volume is 0.86

ATR

$1.01
NVCR average true range is $1.01

10-day Historical Volatility

77.66%
NVCR 10-day historical volatility is 77.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$605.22M
NVCR annual revenue is $605.22 million

Revenue Analysts estimate

$612.23M
NVCR annual revenue is currently -1.15% lower than the consensus analysts' forecast

Revenue 1-year change

+18.82%
NVCR annual revenue is up +18.82% year-on-year

Revenue Sector rank

75.34%
NVCR annual revenue is higher than 75.34% of companies in Healthcare sector

EPS

EPS

-$1.56
NVCR annual earnings per share is -$1.56

EPS Analysts estimate

-$1.98
NVCR annual earnings per share is currently -21.37% lower than the consensus analysts' forecast

EPS 1-year change

+20%
NVCR annual earnings per share is up +20% year-on-year

EPS Sector rank

44.32%
NVCR annual earnings per share is higher than 44.32% of companies in Healthcare sector

Profit

Gross profit

$468.04M
NVCR annual gross profit is $468.04 million

Gross margin

77.33%
NVCR annual gross profit margin is 77.33%

Operating profit

-$170.50M
NVCR annual operating income is -$170.50 million

Operating margin

-28.17%
NVCR annual operating profit margin is -28.17%

Net income

-$168.63M
NVCR annual net profit is -$168.63 million

Net margin

-27.86%
NVCR annual net profit margin is -27.86%

Expenses

Total expenses

$775.72M
NVCR annual total expenses is $775.72 million

Operating expenses

$638.53M
NVCR annual total operating expenses is $638.53 million

Cost of goods sold

$137.18M
NVCR annual cost of goods sold is $137.18 million

Selling, general & administrative expenses

$428.89M
NVCR annual SGA is $428.89 million

Depreciation and amortization

$11.23M
NVCR annual depreciation & amortization is $11.23 million

Interest expense

$10.34M
NVCR annual interest expense is $10.34 million

Income tax

$37.47M
NVCR annual income tax is $37.47 million

EBIT & EBITDA

EBIT

-$120.82M
NVCR annual earnings before interest & taxes is -$120.82 million

EBITDA

-$109.58M
NVCR annual EBITDA is -$109.58 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.24B
NVCR annual total assets is $1.24 billion

Non current assets

$134.21M
NVCR annual long term assets is $134.21 million

Current assets

$1.11B
NVCR annual total current assets is $1.11 billion

Cash and cash equivalents

$163.77M
NVCR annual cash & cash equivalents is $163.77 million

Accounts receivable

$74.23M
NVCR annual accounts receivable is $74.23 million

Inventory

$35.09M
NVCR annual inventory is $35.09 million

Liabilities

Total liabilities

$880.61M
NVCR annual total liabilities is $880.61 million

Long term liabilities

$124.23M
NVCR annual total long term liabilities is $124.23 million

Current liabilities

$756.38M
NVCR annual total current liabilities is $756.38 million

Accounts payable

$105.09M
NVCR annual accounts payable is $105.09 million

Debt

Total debt

$683.35M
NVCR annual total debt is $683.35 million

Total debt 1-year change

+13.03%
NVCR annual total debt is up +13.03% year-on-year

Long term debt

$117.27M
NVCR annual long term debt is $117.27 million

Short term debt

$566.08M
NVCR annual short term debt is $566.08 million

Equity & Capital

Shareholders equity

$360.18M
NVCR annual stockholders equity is $360.18 million

Book value

$360.18M
NVCR annual book value is $360.18 million

Retained earnings

-$1.15B
NVCR annual retained earnings is -$1.15 billion

Working capital

$350.20M
NVCR annual working capital is $350.20 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$26.37M
NVCR annual cash flow from operations is -$26.37 million

Cash from operations 1-year change

+64.04%
NVCR annual cash flow from operations is up +64.04% year-on-year

Cash from investing

-$140.24M
NVCR annual cash flow from investing activities is -$140.24 million

Cash from investing 1-year change

-176.16%
NVCR annual cash flow from investing activities is down -176.16% year-on-year

Cash from financing

$90.31M
NVCR annual cash flow from financing activities is $90.31 million

Cash from financing 1-year change

+472.08%
NVCR annual cash flow from financing activities is up +472.08% year-on-year

CAPEX

CAPEX

$42.85M
NVCR annual capital expenditures is $42.85 million

CAPEX 1-year change

+58.18%
NVCR annual capital expenditures is up +58.18% year-on-year

Free Cash Flow

Free cash flow

-$69.22M
NVCR annual free cash flow is -$69.22 million

Free cash flow 1-year change

+31.07%
NVCR annual free cash flow is up +31.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

77.33%
NVCR annual gross profit margin is 77.33%

Operating margin

-28.17%
NVCR annual operating profit margin is -28.17%

Net margin

-27.86%
NVCR annual net profit margin is -27.86%

ROA & ROE

ROA

-14.13%
NVCR annual return on assets is -14.13%

ROE

-46.67%
NVCR annual return on equity is -46.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NVCR price to earnings ratio value is unknown

PE ratio Sector rank

-
NVCR price to earnings ratio is unknown

PB Ratio

PB ratio

4.75
NVCR price to book ratio is 4.75

PB ratio Sector rank

82.45%
NVCR price to book ratio is higher than 82.45% of companies in Healthcare sector

PS Ratio

PS ratio

2.83
NVCR price to sales ratio is 2.83

PS ratio Sector rank

50.64%
NVCR price to sales ratio is higher than 50.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.23B
NVCR enterprise value is $2.23 billion

Enterprise value Sector rank

83.15%
NVCR enterprise value is higher than 83.15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-20.37
NVCR EV/EBITDA is -20.37

EV/EBITDA Sector rank

6.09%
NVCR EV/EBITDA is higher than 6.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.46
NVCR annual current ratio is 1.46

Quick ratio

1.42
NVCR annual quick ratio is 1.42

Leverage

Debt to equity

1.82
NVCR annual debt to equity ratio is 1.82

Interest coverage ratio

-11.68
NVCR annual interest coverage ratio is -11.68

Risk & Stability

Piotroski F-Score

4
NVCR piotroski f-score is 4

Altman Z-Score

0.37
NVCR altman z-score is 0.37

Analyst ratings

Recent major analysts updates

Apr 16, 25 Wedbush
Neutral
Apr 10, 25 JP Morgan
Neutral
Jan 14, 25 HC Wainwright & Co.
Buy
Dec 13, 24 Piper Sandler
Overweight
Dec 3, 24 HC Wainwright & Co.
Buy
Dec 2, 24 HC Wainwright & Co.
Buy
Dec 2, 24 Evercore ISI Group
Outperform
Nov 21, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Oct 16, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

SUPN logo
Supernus Pharmaceuticals (SUPN)
GDRX logo
GoodRx Holdings (GDRX)
WRBY logo
Warby Parker (WRBY)
QDEL logo
QuidelOrtho (QDEL)
KYMR logo
Kymera Therapeutics (KYMR)
JANX logo
Janux Therapeutics (JANX)
PINC logo
Premier (PINC)
AGL logo
agilon health (AGL)
Ascentage Pharma Group International (AAPG)
  • What is the ticker symbol for NovoCure Limited?
  • Does NovoCure Limited pay dividends?
  • What sector is NovoCure Limited in?
  • What industry is NovoCure Limited in?
  • What country is NovoCure Limited based in?
  • When did NovoCure Limited go public?
  • Is NovoCure Limited in the S&P 500?
  • Is NovoCure Limited in the NASDAQ 100?
  • Is NovoCure Limited in the Dow Jones?
  • When was NovoCure Limited's last earnings report?
  • When does NovoCure Limited report earnings?
  • Should I buy NovoCure Limited stock now?

What is the ticker symbol for NovoCure Limited?

The ticker symbol for NovoCure Limited is NASDAQ:NVCR

Does NovoCure Limited pay dividends?

No, NovoCure Limited does not pay dividends

What sector is NovoCure Limited in?

NovoCure Limited is in the Healthcare sector

What industry is NovoCure Limited in?

NovoCure Limited is in the Medical Devices industry

What country is NovoCure Limited based in?

NovoCure Limited is headquartered in Switzerland

When did NovoCure Limited go public?

NovoCure Limited's initial public offering (IPO) was on October 1, 2015

Is NovoCure Limited in the S&P 500?

No, NovoCure Limited is not included in the S&P 500 index

Is NovoCure Limited in the NASDAQ 100?

No, NovoCure Limited is not included in the NASDAQ 100 index

Is NovoCure Limited in the Dow Jones?

No, NovoCure Limited is not included in the Dow Jones index

When was NovoCure Limited's last earnings report?

NovoCure Limited's most recent earnings report was on Feb 27, 2025

When does NovoCure Limited report earnings?

The next expected earnings date for NovoCure Limited is Apr 24, 2025

Should I buy NovoCure Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page